Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats

References

Page 1

	Year	Citations
Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel Olivier Rixe, Waldo Ortuzar, Manuel Álvarez, Biochemical Pharmacology National Cancer InstituteMedicinePharmacologyCell LinesDrug-resistant Cell Lines	1996	612
Oxaliplatin: mechanism of action and antineoplastic activity. Éric Raymond, Sandrine Faivre, Jan M. Woynarowski, PubMed	1998	523
Cisplatin Binding Sites on Human Albumin Andrei I. Ivanov, John Christodoulou, John A. Parkinson, Journal of Biological Chemistry	1998	355
Preclinical studies identifying carboplatin as a viable cisplatin alternative Kenneth R. Harrap Cancer Treatment Reviews ChromatinMedicineViable Cisplatin AlternativeAnti-cancer AgentCancer Treatment	1985	253
In vitro cytotoxicity, protein binding, red blood cell partitioning, and biotransformation of oxaliplatin. Lakshmi Pendyala, Patrick J. Creaven PubMed Whole BloodGliomaRedox BiologyTumor BiologyOxidative Stress	1993	208
Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys. John A. Levi, Charlotte Jacobs, S M Kalman, Journal of Pharmacology and Experimental Therapeutics	1980	148
The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats Zahid H. Siddik, David R. Newell, Frances Boxall, Biochemical Pharmacology Pharmacological StudyMedicinePharmacologyPharmacotherapyComparative Pharmacokinetics	1987	138
Oxaliplatin: a new therapeutic option in colorectal cancer. Esteban Cvitkovic, M. Bekradda PubMed	1999	115
Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors. A. Horwich, David P. Dearnaley, J. Nicholls, Journal of Clinical Oncology Surgical OncologyCancer ManagementBleomycin Combination ChemotherapyCeb ChemotherapyGynecology	1991	101
Pharmacokinetics of oxaliplatin in patients with normal versus impaired renal function Claire Massari, S. Brienza, Mathieu Rotarski, Cancer Chemotherapy and Pharmacology UrologyRenal FunctionChronic Kidney DiseasePharmacologyPharmacotherapy	2000	95

Page 1